IL1B and Hyperglycemia: IL-1β activated by NLRP3 inflammasome can worse insulin resistance in human adipocytes (Gao et al., 2014), moreover, inhibition of IL-1β can reduce hyperglycemia in obese/diabetic rats (Ehses et al., 2009).